(HOMB) Home BancShares - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4368932004
HOMB: Banking, Loans, Insurance, Investments, Financial Services
Home Bancshares, Inc. (NYSE:HOMB), headquartered in Conway, Arkansas, operates as a bank holding company for Centennial Bank, offering a diverse range of commercial and retail banking services. The company serves businesses, real estate developers, municipalities, and individual clients across Arkansas, Florida, South Alabama, Texas, and New York City. Its product suite includes checking, savings, and money market accounts, as well as certificates of deposit. The bank also specializes in various loan categories, such as non-farm/non-residential real estate, construction/land development, residential mortgages, consumer loans, agricultural loans, and commercial and industrial loans. Additionally, Home Bancshares provides digital banking solutions, cash management services, overdraft protection, and safe deposit boxes. The company further extends its offerings into insurance, providing commercial and personal lines coverage, including property, casualty, life, health, and employee benefits insurance. Founded in 1903, Home Bancshares has established a strong presence in its markets, focusing on community banking and customer-centric financial solutions.
As of the latest data, Home Bancshares operates with a market capitalization of $5.22 billion, reflecting its scale in the regional banking sector. The stock currently trades at $27.69, with a trailing P/E ratio of 12.59 and a forward P/E of 12.03, indicating moderate valuation relative to earnings. The price-to-book ratio of 1.30 suggests a slight premium to book value, while the price-to-sales ratio of 5.28 highlights its revenue multiple. The companys return on equity stands at 10.15%, demonstrating its ability to generate profits from shareholder equity. Technically, the stock has averaged 1.17 million shares traded over the past 20 days, with a 20-day SMA of $26.61, 50-day SMA of $28.02, and 200-day SMA of $27.96. The average true range (ATR) of 0.95 reflects moderate price volatility.
3-Month Forecast Based on the providedAdditional Sources for HOMB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HOMB Stock Overview
Market Cap in USD | 5,556m |
Sector | Financial Services |
Industry | Banks - Regional |
GiC Sub-Industry | Regional Banks |
IPO / Inception | 2006-06-23 |
HOMB Stock Ratings
Growth Rating | 71.0 |
Fundamental | 62.3 |
Dividend Rating | 76.8 |
Rel. Strength | -2.28 |
Analysts | 3.88/5 |
Fair Price Momentum | 27.56 USD |
Fair Price DCF | 27.09 USD |
HOMB Dividends
Dividend Yield 12m | 3.50% |
Yield on Cost 5y | 7.78% |
Annual Growth 5y | 7.19% |
Payout Consistency | 99.4% |
HOMB Growth Ratios
Growth Correlation 3m | -87.2% |
Growth Correlation 12m | 67.7% |
Growth Correlation 5y | 69.8% |
CAGR 5y | 17.69% |
CAGR/Max DD 5y | 0.65 |
Sharpe Ratio 12m | 0.18 |
Alpha | 8.10 |
Beta | 0.857 |
Volatility | 26.85% |
Current Volume | 948.1k |
Average Volume 20d | 1172.5k |
As of May 02, 2025, the stock is trading at USD 28.04 with a total of 948,123 shares traded.
Over the past week, the price has changed by +0.79%, over one month by -0.64%, over three months by -5.69% and over the past year by +19.88%.
Yes, based on ValueRay Fundamental Analyses, Home BancShares (NYSE:HOMB) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 62.25 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HOMB as of May 2025 is 27.56. This means that HOMB is currently overvalued and has a potential downside of -1.71%.
Home BancShares has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy HOMB.
- Strong Buy: 3
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, HOMB Home BancShares will be worth about 31.2 in May 2026. The stock is currently trading at 28.04. This means that the stock has a potential upside of +11.2%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 32 | 14.1% |
Analysts Target Price | 32 | 14.1% |
ValueRay Target Price | 31.2 | 11.2% |